Monoclonal IgE antibody that binds to sweat allergy antigen protein

US9989538B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9989538-B2
Application numberUS-201314421821-A
CountryUS
Kind codeB2
Filing dateAug 9, 2013
Priority dateAug 17, 2012
Publication dateJun 5, 2018
Grant dateJun 5, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided include a human IgE antibody that binds to a sweat allergy antigen protein and a human high-affinity IgE receptor but does not induce degranulation in a reaction with the sweat allergy antigen protein, and a composition for treatment or diagnosis of sweat allergy comprising the same.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of measuring an amount of a sweat allergy antibody in a sample from a human, comprising (a) contacting the sample comprising the sweat allergy antibody with a sweat allergy antigen protein having an amino acid sequence consisting of SEQ ID NO: 1 to form a complex and detecting the complex; and (b) determining the amount of the sweat allergy antibody in the sample based on a standard curve prepared by contacting a known concentration of a standard antibody with the sweat allergy antigen protein having an amino acid sequence consisting of SEQ ID NO: 1, wherein the standard antibody is a human IgE monoclonal antibody, clone HE1, that specifically binds to the sweat allergy antigen protein having an amino acid sequence consisting of SEQ ID NO: 1. 2. The method of claim 1 , wherein the sweat allergy antibody is an IgE antibody. 3. The method of claim 1 , wherein the amount of the sweat allergy antibody is measured in an ELISA plate on which the sweat allergy antigen protein is immobilized or an ELISA plate on which the sample is immobilized. 4. The method of claim 1 , wherein said standard antibody does not induce degranulation in a reaction with the sweat allergy antigen protein having an amino acid sequence consisting of SEQ ID NO: 1.

Assignees

Inventors

Classifications

  • Antiallergic agents (antiasthmatic agents A61P11/06; ophthalmic antiallergics A61P27/14) · CPC title

  • C07K16/14Primary

    against material from fungi, algea or lichens · CPC title

  • against material from animals or humans · CPC title

  • against enzymes · CPC title

  • from primates, e.g. man · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9989538B2 cover?
Provided include a human IgE antibody that binds to a sweat allergy antigen protein and a human high-affinity IgE receptor but does not induce degranulation in a reaction with the sweat allergy antigen protein, and a composition for treatment or diagnosis of sweat allergy comprising the same.
Who is the assignee on this patent?
Univ Hiroshima
What technology area does this patent fall under?
Primary CPC classification C07K16/14. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 05 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).